92 related articles for article (PubMed ID: 22512090)
1. The function of calcineurin and ERK1/2 signal in the antihypertrophic effects of kappa-opioid receptor stimulation on myocardial hypertrophy induced by isoprenaline.
Lu M; Wang H; Yang Y; Zhang L; Liu C; Yang J; Wong TM
Pharmazie; 2012 Feb; 67(2):182-6. PubMed ID: 22512090
[TBL] [Abstract][Full Text] [Related]
2. kappa-opioid receptor stimulation inhibits cardiac hypertrophy induced by beta1-adrenoceptor stimulation in the rat.
Shan D; Wang H; Su Y; Jing Y; Wong TM
Eur J Pharmacol; 2007 Jan; 555(2-3):100-5. PubMed ID: 17126321
[TBL] [Abstract][Full Text] [Related]
3. kappa-Opioid receptor stimulation inhibits augmentation of Ca(2+) transient and hypertrophy induced by isoprenaline in neonatal rat ventricular myocytes - Role of CaMKIIdelta(B).
Wu G; Wang H; Yang J; Yang Y; Liu C; Jing L; Wong TM
Eur J Pharmacol; 2008 Oct; 595(1-3):52-7. PubMed ID: 18721804
[TBL] [Abstract][Full Text] [Related]
4. Stimulation of kappa-opioid receptor reduces isoprenaline-induced cardiac hypertrophy and fibrosis.
Yin W; Zhang P; Huang JH; Zhang QY; Fan R; Li J; Zhou JJ; Hu YZ; Guo HT; Zhang SM; Wang YM; Kaye AD; Gu CH; Liu JC; Cheng L; Cui Q; Yi DH; Pei JM
Eur J Pharmacol; 2009 Apr; 607(1-3):135-42. PubMed ID: 19233160
[TBL] [Abstract][Full Text] [Related]
5. Kappa-opioid receptor stimulation inhibits growth of neonatal rat ventricular myocytes.
Wang G; Wang H; Yang Y; Wong TM
Eur J Pharmacol; 2004 Sep; 498(1-3):53-8. PubMed ID: 15363975
[TBL] [Abstract][Full Text] [Related]
6. Anti-arrhythmic effect of kappa-opioid receptor stimulation in the perfused rat heart: involvement of a cAMP-dependent pathway.
Yu XC; Wang HX; Pei JM; Wong TM
J Mol Cell Cardiol; 1999 Oct; 31(10):1809-19. PubMed ID: 10525419
[TBL] [Abstract][Full Text] [Related]
7. Effects of kappa-opioid receptor stimulation in the heart and the involvement of protein kinase C.
Bian JS; Wang HX; Zhang WM; Wong TM
Br J Pharmacol; 1998 Jun; 124(3):600-6. PubMed ID: 9647487
[TBL] [Abstract][Full Text] [Related]
8. [Inhibitory effects of kappa-opioid receptor stimulation on cultured myocardial cells].
Yang YL; Wang HX; Yang YH
Zhongguo Ying Yong Sheng Li Xue Za Zhi; 2002 Nov; 18(4):358-61. PubMed ID: 21174814
[TBL] [Abstract][Full Text] [Related]
9. Cross-talk between cardiac kappa-opioid and beta-adrenergic receptors in developing hypertensive rats.
Yu XC; Wang HX; Zhang WM; Wong TM
J Mol Cell Cardiol; 1999 Mar; 31(3):597-605. PubMed ID: 10198190
[TBL] [Abstract][Full Text] [Related]
10. kappa -opioid receptor stimulation induces arrhythmia in the isolated rat heart via the protein kinase C/Na(+)-H(+)exchange pathway.
Bian JS; Pei JM; Cheung CS; Zhang WM; Wong TM
J Mol Cell Cardiol; 2000 Aug; 32(8):1415-27. PubMed ID: 10900168
[TBL] [Abstract][Full Text] [Related]
11. U50,488H inhibits effects of norepinephrine in rat cardiomyocytes-cross-talk between kappa-opioid and beta-adrenergic receptors.
Yu XC; Li HY; Wang HX; Wong TM
J Mol Cell Cardiol; 1998 Feb; 30(2):405-13. PubMed ID: 9515017
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of [3H]-U69593 binding and the cardiac effects of U50, 488H by calcium channel blockers in the rat heart.
Zhang WM; Wang HX; Xia Q; Wong TM
Br J Pharmacol; 1997 Mar; 120(5):827-32. PubMed ID: 9138688
[TBL] [Abstract][Full Text] [Related]
13. Signaling pathway mediated by kappa-opioid receptor is impaired in cardiac hypertrophy.
Pei JM; Wang YM; Zhu YL; Chen M; Wong TM
Acta Pharmacol Sin; 2001 Oct; 22(10):887-95. PubMed ID: 11749770
[TBL] [Abstract][Full Text] [Related]
14. Effect of U50,488H, a κ-opioid receptor agonist on myocardial α-and β-myosin heavy chain expression and oxidative stress associated with isoproterenol-induced cardiac hypertrophy in rat.
Jaiswal A; Kumar S; Seth S; Dinda AK; Maulik SK
Mol Cell Biochem; 2010 Dec; 345(1-2):231-40. PubMed ID: 20730476
[TBL] [Abstract][Full Text] [Related]
15. K(ATP) channels mediate the antihypertrophic effects afforded by κ-opioid receptor stimulation in neonatal rat ventricular myocytes.
Zhang L; Wang H; Lu M; Wu G; Yang Y; Liu C; Maslov LN
Exp Ther Med; 2012 Aug; 4(2):261-266. PubMed ID: 23139715
[TBL] [Abstract][Full Text] [Related]
16. Activation of ERK and suppression of calcineurin are interacting mechanisms of cardioprotection afforded by delta-opioid receptor activation.
Ikeda Y; Miura T; Sakamoto J; Miki T; Tanno M; Kobayashi H; Ohori K; Takahashi A; Shimamoto K
Basic Res Cardiol; 2006 Sep; 101(5):418-26. PubMed ID: 16619106
[TBL] [Abstract][Full Text] [Related]
17. The role of phosphodiesterase in mediating the effect of protein kinase C on cyclic AMP accumulation upon kappa-opioid receptor stimulation in the rat heart.
Bian JS; Zhang WM; Pei JM; Wong TM
J Pharmacol Exp Ther; 2000 Mar; 292(3):1065-70. PubMed ID: 10688624
[TBL] [Abstract][Full Text] [Related]
18. Vasorelaxing effect of U50,488H in pulmonary artery and underlying mechanism in rats.
Sun X; Ma S; Zang YM; Lu SY; Guo HT; Bi H; Wang YM; Ma H; Ma XL; Pei JM
Life Sci; 2006 Apr; 78(21):2516-22. PubMed ID: 16336977
[TBL] [Abstract][Full Text] [Related]
19. Delayed uncoupling is related to cardioprotection induced by kappa-agonist U-50,488H in rat heart.
Chen BP; Mao HJ; Fan FY; Bruce IC; Xia Q
Scand Cardiovasc J; 2005 Dec; 39(6):375-82. PubMed ID: 16352491
[TBL] [Abstract][Full Text] [Related]
20. Activation of the cloned human kappa opioid receptor by agonists enhances [35S]GTPgammaS binding to membranes: determination of potencies and efficacies of ligands.
Zhu J; Luo LY; Li JG; Chen C; Liu-Chen LY
J Pharmacol Exp Ther; 1997 Aug; 282(2):676-84. PubMed ID: 9262330
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
